Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection: 2024 Update.

Surgical infections·2024
Same author

Surgical Infection Society Guidelines for Total Abdominal Colectomy versus Diverting Loop Ileostomy with Antegrade Intra-Colonic Lavage for the Surgical Management of Severe or Fulminant, Non-Perforated <i>Clostridioides difficile</i> Colitis.

Surgical infections·2021
Same author

Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections.

Surgical infections·2021
Same author

Necrotizing Soft Tissue Infections: A Focused Review of Pathophysiology, Diagnosis, Operative Management, Antimicrobial Therapy, and Pediatrics.

Surgical infections·2019
Same author

A Young Adult from the Middle East with Septic Shock, Pancytopenia, and Systolic Dysfunction.

Annals of the American Thoracic Society·2019
Same author

Biomarkers of endothelial activation/dysfunction distinguish sub-groups of Ugandan patients with sepsis and differing mortality risks.

JCI insight·2019

Related Experiment Video

Updated: Jun 16, 2026

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

Principles of antimicrobial therapy.

Jeffrey M Tessier1, W Michael Scheld

  • 1Virginia Commonwealth University, Richmond, 23298-0049, USA. jmtessier@vcu.edu

Handbook of Clinical Neurology
|January 30, 2010
PubMed
Summary
This summary is machine-generated.

Choosing effective antimicrobial treatments for bacterial meningitis and brain abscess involves selecting bactericidal drugs that cross the blood-brain barrier. Tailor therapy based on pathogen and clinical response, ensuring adequate duration for CNS infections.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pharmacology

Background:

  • Central nervous system (CNS) infections like bacterial meningitis and brain abscess require careful antimicrobial selection.
  • Optimal antimicrobial therapy principles for these conditions may extend to other CNS infections.
  • Limited pharmacological data exists for non-bacterial CNS infections.

Purpose of the Study:

  • To discuss key factors in selecting antimicrobial regimens for bacterial meningitis and brain abscess.
  • To highlight common themes in treating CNS infections.
  • To provide guidance on antimicrobial therapy based on current understanding.

Main Methods:

  • Review of pharmacological and microbiological aspects of antimicrobial therapy for CNS infections.
  • Emphasis on studies in experimental animal models and human data.
  • Summary of current understanding of appropriate antimicrobial therapy.

Main Results:

  • Bactericidal antimicrobials crossing the blood-brain barrier (BBB) are crucial for achieving high cerebrospinal fluid (CSF) concentrations.
  • Pharmacodynamic (PD) parameters like time above minimum bactericidal concentration (MBC) are important.
  • Tailoring therapy based on microbiological data, including consideration for anaerobes in brain abscess, is recommended.

Conclusions:

  • Bacterial meningitis treatment duration varies: 7-10 days for non-meningococcal, 3-4 days for meningococcal, guided by clinical response.
  • Brain abscess treatment requires at least 6 weeks of intravenous antimicrobials post-drainage, monitored by clinical and radiographic improvement.
  • Effective antimicrobial therapy for CNS infections necessitates careful drug selection, consideration of PD, and tailored treatment duration.